Beijing GoBroad Hospital

• The hospital, which combines clinical treatment with state-of-the-art research and innovation, is a research-focused international medical centre situated in Beijing's Changping Life Science Park.
• Eight stories above ground and three below ground levels make up the approximately 97,000–100,000-square-meter campus, which is intended to serve both medical care and research endeavours.
• 500 beds are anticipated, of which 100 will be used for early-stage clinical research on complex and serious illnesses.
• Specialised care offers comprehensive treatment approaches with a focus on key clinical areas, including solid tumours, hematologic malignancies, and neurosciences.
• Early-stage clinical investigations in pharmacology and medical devices are supported by the hospital's Phase I Clinical Trial Unit and other research-focused departments.
• To provide individualised, evidence-based medical care, the infrastructure comprises state-of-the-art diagnostic and treatment facilities that integrate advanced technology.
• Translational research is facilitated by integrated research laboratories, including central labs and specialised cores, in conjunction with clinical services.
• With services ranging from specialised inpatient care to outpatient diagnostics, the hospital provides extensive multidisciplinary clinical departments.
• The infrastructure facilitates a smooth transition between clinical discovery, medical delivery, and industrial transformation because it was designed with patient care and research synergy in mind.
• Additionally, the hospital provides infrastructure to support international patient services, including bilingual support and care coordination before and after treatment.

Building 1, No.4 Science Park Road, Life Science Park, Changping District, Beijing, China

Distance from Airport : 43 km

Distance from Railway Station : 32 km

• National Recognition in Transplant Medicine: GoBroad-affiliated haematology institutions, including Shanghai ZhaXin and LiQuan centres, have been ranked among China’s Top 30 hematopoietic stem cell transplant centres for three consecutive years, reflecting sustained excellence in complex transplant care.
• International Professional Acceptance: In 2025, GoBroad haematology programs were formally admitted to the European Society for Blood and Marrow Transplantation (EBMT), underscoring compliance with internationally recognised clinical and research standards.
• Prestigious Scientific & Technological Awards: Senior physicians and research teams associated with GoBroad have received multiple high-level national honours for advancements in haematology and oncology, including:
• Second Prize, Scientific and Technological Progress Award from the Ministry of Education of China and the Chinese Medical Association for pioneering work in allogeneic HSCT for refractory malignant hematologic diseases.
• Chinese Medical Science and Technology Award for contributions to clinical innovation.
• Chinese Pharmaceutical Association Science and Technology Innovation Award recognising translational research impact.
• Beijing Science and Technology Award for advancements in medical science and patient outcomes.
• Chinese Anti-Cancer Association Science and Technology Award for leadership in oncology research.
• Leadership in Advanced Therapies: Beijing GoBroad Hospital is widely recognised as a leading centre for CAR-T cell therapy, integrating clinical care with cutting-edge research and innovation.